Resmed (RMD) Total Liabilities (2010 - 2026)

Resmed's Total Liabilities history runs 17 years deep, the most recent figure standing at $2.3 billion for Q1 2026.

• Quarterly Total Liabilities rose 13.45% year-over-year to $2.3 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.3 billion (up 13.45% YoY) and the FY2025 annual result came in at $2.2 billion, up 9.87% from the prior year.
• Total Liabilities was $2.3 billion for Q1 2026 at Resmed, up from $2.2 billion in the prior quarter.
• Across five years, Total Liabilities topped out at $2.9 billion in Q4 2022 and bottomed at $1.6 billion in Q1 2022.
• A 5-year average of $2.2 billion and a median of $2.2 billion in 2024 frame the typical range for Total Liabilities.
• Annual changes were most pronounced in 2022 — Total Liabilities surged 84.91% — and 2024, when it decreased 23.4%.
• Resmed's Total Liabilities stood at $2.9 billion in 2022, then retreated by 17.52% to $2.4 billion in 2023, then retreated by 22.07% to $1.9 billion in 2024, then advanced by 15.58% to $2.2 billion in 2025, then gained by 5.03% to $2.3 billion in 2026.
• Business Quant data shows RMD's Total Liabilities at $2.3 billion in Q1 2026, $2.2 billion in Q4 2025, and $2.2 billion in Q3 2025.